X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (99041) 99041
Newsletter (12362) 12362
Newspaper Article (2767) 2767
Book Chapter (540) 540
Dissertation (447) 447
Magazine Article (399) 399
Publication (120) 120
Book / eBook (95) 95
Transcript (93) 93
Conference Proceeding (87) 87
Government Document (41) 41
Web Resource (38) 38
Reference (35) 35
Trade Publication Article (33) 33
Book Review (8) 8
Journal / eJournal (8) 8
Paper (7) 7
Report (2) 2
Streaming Video (2) 2
Video Recording (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (47746) 47746
proteases (35785) 35785
animals (30607) 30607
protease inhibitors (30052) 30052
biochemistry & molecular biology (18450) 18450
male (17373) 17373
female (15065) 15065
research (14127) 14127
protease inhibitors - pharmacology (12012) 12012
proteins (11637) 11637
protease (10564) 10564
adult (9442) 9442
hiv infections - drug therapy (9349) 9349
mice (9236) 9236
analysis (9162) 9162
hiv (8675) 8675
pharmacology & pharmacy (8478) 8478
amino acid sequence (8321) 8321
expression (7886) 7886
immunology (7770) 7770
molecular sequence data (7767) 7767
middle aged (7485) 7485
cell biology (7343) 7343
infectious diseases (7214) 7214
apoptosis (7127) 7127
rats (7030) 7030
enzymes (6707) 6707
health aspects (6089) 6089
microbiology (6023) 6023
kinetics (5651) 5651
physiological aspects (5578) 5578
protease inhibitor (5318) 5318
virology (5142) 5142
inhibitors (5123) 5123
cancer (4861) 4861
activation (4849) 4849
antiviral agents (4848) 4848
peptides (4840) 4840
chemistry, medicinal (4812) 4812
models, molecular (4748) 4748
research article (4708) 4708
hiv protease inhibitors - therapeutic use (4643) 4643
aids (4536) 4536
mutation (4457) 4457
universities and colleges (4446) 4446
proteolysis (4443) 4443
drug therapy (4112) 4112
substrate specificity (4112) 4112
oncology (4111) 4111
cells, cultured (4110) 4110
gene expression (4108) 4108
purification (4073) 4073
binding sites (4049) 4049
identification (3985) 3985
protein binding (3966) 3966
drug therapy, combination (3939) 3939
cell line (3913) 3913
multidisciplinary sciences (3911) 3911
biochemistry (3833) 3833
structure-activity relationship (3805) 3805
genetic aspects (3775) 3775
anti-hiv agents - therapeutic use (3755) 3755
cells (3727) 3727
aged (3614) 3614
care and treatment (3610) 3610
biophysics (3581) 3581
in-vitro (3501) 3501
protease inhibitors - therapeutic use (3394) 3394
antiretroviral therapy (3362) 3362
inhibitor (3349) 3349
medicine (3284) 3284
life sciences (3282) 3282
medical research (3230) 3230
chemistry, organic (3224) 3224
hydrogen-ion concentration (3198) 3198
hiv infections - virology (3182) 3182
time factors (3178) 3178
inflammation (3157) 3157
infection (3134) 3134
hiv-1 - drug effects (3081) 3081
protease inhibitors - chemistry (3044) 3044
biotechnology & applied microbiology (3037) 3037
thrombin (2990) 2990
molecular weight (2979) 2979
binding (2934) 2934
viral load (2925) 2925
cysteine (2915) 2915
crystal-structure (2909) 2909
hiv protease inhibitors - pharmacology (2891) 2891
biology (2882) 2882
peptide hydrolases - metabolism (2827) 2827
human immunodeficiency virus--hiv (2825) 2825
treatment outcome (2772) 2772
dose-response relationship, drug (2762) 2762
protein conformation (2751) 2751
hepatitis c virus (2747) 2747
inhibition (2743) 2743
therapy (2742) 2742
amino acids (2735) 2735
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (64) 64
Online Resources - Online (32) 32
Collection Dvlpm't (Acquisitions) - Closed Orders (8) 8
Collection Dvlpm't (Acquisitions) - Vendor file (5) 5
Chemistry (A D Allen) - Stacks (4) 4
Chemistry (A D Allen) - May be requested in 6-10 wks (1) 1
Earth Sciences (Noranda) - Stacks (1) 1
Media Commons - Audio Visual (1) 1
Robarts - Stacks (1) 1
UTL at Downsview - May be requested (1) 1
UofT at Mississauga - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (113012) 113012
Japanese (1387) 1387
Russian (789) 789
German (722) 722
French (592) 592
Spanish (479) 479
Portuguese (398) 398
Chinese (201) 201
Polish (104) 104
Italian (82) 82
Czech (50) 50
Korean (48) 48
Hungarian (35) 35
Dutch (31) 31
Norwegian (22) 22
Ukrainian (21) 21
Danish (16) 16
Slovak (12) 12
Swedish (12) 12
Turkish (8) 8
Croatian (7) 7
Bulgarian (6) 6
Hebrew (5) 5
Romanian (5) 5
Finnish (3) 3
Indonesian (3) 3
Persian (3) 3
Serbian (3) 3
Slovenian (3) 3
Arabic (2) 2
Catalan (2) 2
Lithuanian (2) 2
Afrikaans (1) 1
Breton (1) 1
Greek (1) 1
Latin (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Annals of internal medicine, ISSN 0003-4819, 2012, Volume 156, Issue 4, pp. 279 - 290
Journal Article
Best Practice & Research: Clinical Endocrinology & Metabolism, ISSN 1521-690X, 2007, Volume 21, Issue 4, pp. 517 - 533
.... Several DPP-4 inhibitors are in clinical development. Most experience so far has been with sitagliptin (Merck... 
Endocrinology & Metabolism | treatment | dipeptidyl peptidase 4 | sitagliptin | type-2 diabetes | vildagliptin | glucagon-like peptide-1 | GLYCEMIC CONTROL | DIPEPTIDYL-PEPTIDASE-IV | INSULIN-SECRETION | IMPROVED GLUCOSE-TOLERANCE | BETA-CELL FUNCTION | METFORMIN-TREATED PATIENTS | ENDOCRINOLOGY & METABOLISM | DOUBLE-BLIND | PLASMA-GLUCOSE | 7-36 AMIDE | Triazoles - adverse effects | Metformin - therapeutic use | Humans | Body Weight - drug effects | Pyrrolidines - adverse effects | Substrate Specificity | Glucagon-Like Peptide 1 - physiology | Pyrazines - therapeutic use | Pyrrolidines - therapeutic use | Thiazolidinediones - therapeutic use | Adamantane - therapeutic use | Sitagliptin Phosphate | Drug Therapy, Combination | Hypoglycemia - chemically induced | Protease Inhibitors - therapeutic use | Insulin Secretion | Adamantane - adverse effects | Adamantane - analogs & derivatives | Triazoles - therapeutic use | Hypoglycemic Agents - therapeutic use | Pioglitazone | Insulin - metabolism | Animals | Dipeptidyl-Peptidase IV Inhibitors | Lipid Metabolism - drug effects | Pyrazines - adverse effects | Glucagon - metabolism | Vildagliptin | Glucagon-Like Peptide 1 - antagonists & inhibitors | Diabetes Mellitus, Type 2 - drug therapy | Nitriles - adverse effects | Insulin - therapeutic use | Nitriles - therapeutic use | Clinical Medicine | Other Clinical Medicine | Medical and Health Sciences | Medicin och hälsovetenskap | Adamantane/adverse effects Adamantane/analogs & derivatives Adamantane/therapeutic use Animals Antigens | Annan klinisk medicin | Combination Glucagon/secretion Glucagon-Like Peptide 1/antagonists & inhibitors Glucagon-Like Peptide 1/physiology Humans Hypoglycemia/chemically induced Hypoglycemic Agents/therapeutic use Insulin/secretion Insulin/therapeutic use Lipid Metabolism/drug effects Metformin/therapeutic use Nitriles/adverse effects Nitriles/therapeutic use Protease Inhibitors/therapeutic use Pyrazines/adverse effects Pyrazines/therapeutic use Pyrrolidines/adverse effects Pyrrolidines/therapeutic use Substrate Specificity Thiazolidinediones/therapeutic use Triazoles/adverse effects Triazoles/therapeutic use | Type 2/drug therapy Drug Therapy | Klinisk medicin | CD26/antagonists & inhibitors Body Weight/drug effects Diabetes Mellitus
Journal Article
International journal of cancer, ISSN 0020-7136, 04/2017, Volume 140, Issue 8, pp. 1713 - 1726
Journal Article
Nature (London), ISSN 1476-4687, 2016, Volume 530, Issue 7589, pp. 233 - 236
.... In particular, proteasome inhibitors have been shown to be toxic for the malaria parasite Plasmodium falciparum at all stages of its life cycle(2-5... 
VISUALIZATION | FALCIPARUM MALARIA | MECHANISM | SPECIFICITY | ARTEMISININ RESISTANCE | MULTIDISCIPLINARY SCIENCES | VALIDATION | ELECTRON-MICROSCOPY | IDENTIFICATION | PARASITE | HUMAN 20S PROTEASOME | Plasmodium falciparum - enzymology | Plasmodium - enzymology | Plasmodium chabaudi - enzymology | Species Specificity | Humans | Proteasome Inhibitors - chemistry | Plasmodium - drug effects | Plasmodium falciparum - drug effects | Protein Subunits - metabolism | Dose-Response Relationship, Drug | Artemisinins - pharmacology | Plasmodium chabaudi - physiology | Drug Design | Plasmodium - growth & development | Female | Drug Resistance | Antimalarials - adverse effects | Catalytic Domain | Proteasome Inhibitors - pharmacology | Models, Molecular | Proteasome Endopeptidase Complex - chemistry | Proteasome Inhibitors - toxicity | Proteasome Inhibitors - adverse effects | Antimalarials - pharmacology | Cryoelectron Microscopy | Drug Synergism | Animals | Substrate Specificity - drug effects | Proteasome Endopeptidase Complex - ultrastructure | Antimalarials - chemistry | Plasmodium chabaudi - drug effects | Mice | Mice, Inbred BALB C | Protein Subunits - antagonists & inhibitors | Protein Subunits - chemistry | Antimalarials - toxicity | Enzyme Activation | Plasmodium falciparum - growth & development | Proteasome Endopeptidase Complex - metabolism | Ubiquitin-proteasome system | Plasmodium | Health aspects | Proteins | Malaria | Protease inhibitors | Proteases | Erythrocytes | Ligands | Parasites | Drug dosages
Journal Article
Journal of Hepatology, ISSN 0168-8278, 2011, Volume 55, Issue 1, pp. 192 - 206
Journal Article
Journal of acquired immune deficiency syndromes (1999), ISSN 1525-4135, 2015, Volume 68, Issue 5, pp. 568 - 577
Journal Article